Sangamo Therapeutics
+$0.16 (+2.56%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell SGMO and other ETFs, options, and stocks.
About SGMO
Sangamo Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the research and development of zinc finger proteins. It focuses on three therapeutic areas: inherited metabolic diseases, central nervous system, and diseases and immunology, which comprises inflammatory and autoimmune diseases.
CEO
Alexander D. Macrae
Employees
413
Headquarters
Brisbane, California
Founded
1995
SGMO Key Statistics
Market cap
932.32M
Price-Earnings ratio
—
Dividend yield
—
Average volume
1.64M
High today
$6.42
Low today
$6.03
Open price
$6.16
Volume
1.14M
52 Week high
$16.79
52 Week low
$6.03
Analyst ratings
73%
of 11 ratings
Buy
72.7%
Hold
27.3%
Sell
0%
SGMO Earnings
-$0.34
-$0.23
-$0.11
$0.00
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Estimated
— per share
Actual
Expected Feb 23, Pre-Market